Aberdeen Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Buy |
81,499
+1,482
| +2% | +$40.9K | ﹤0.01% | 774 |
|
|
2025
Q1 | $2.27M | Sell |
80,017
-235,895
| -75% | -$6.68M | ﹤0.01% | 750 |
|
|
2024
Q4 | $12.8M | Buy |
315,912
+69,360
| +28% | +$2.82M | 0.02% | 464 |
|
|
2024
Q3 | $16.3M | Sell |
246,552
-46,110
| -16% | -$3.05M | 0.03% | 432 |
|
|
2024
Q2 | $34.8M | Sell |
292,662
-170,452
| -37% | -$20.2M | 0.07% | 267 |
|
|
2024
Q1 | $49.3M | Sell |
463,114
-20,460
| -4% | -$2.18M | 0.1% | 221 |
|
|
2023
Q4 | $48.1M | Buy |
483,574
+399,843
| +478% | +$39.8M | 0.1% | 212 |
|
|
2023
Q3 | $8.65M | Sell |
83,731
-5,374
| -6% | -$555K | 0.02% | 473 |
|
|
2023
Q2 | $10.8M | Sell |
89,105
-3,509
| -4% | -$426K | 0.03% | 461 |
|
|
2023
Q1 | $14.2M | Sell |
92,614
-1,527
| -2% | -$235K | 0.04% | 401 |
|
|
2022
Q4 | $16.9M | Buy |
94,141
+8,061
| +9% | +$1.45M | 0.05% | 367 |
|
|
2022
Q3 | $10.2M | Sell |
86,080
-15,293
| -15% | -$1.81M | 0.03% | 428 |
|
|
2022
Q2 | $14.6M | Sell |
101,373
-1,025
| -1% | -$147K | 0.05% | 353 |
|
|
2022
Q1 | $17.9M | Sell |
102,398
-15,161
| -13% | -$2.65M | 0.05% | 326 |
|
|
2021
Q4 | $29.9M | Sell |
117,559
-5,048
| -4% | -$1.28M | 0.07% | 271 |
|
|
2021
Q3 | $47.2M | Buy |
122,607
+90,699
| +284% | +$34.9M | 0.11% | 197 |
|
|
2021
Q2 | $7.5M | Buy |
31,908
+74
| +0.2% | +$17.4K | 0.02% | 565 |
|
|
2021
Q1 | $4.17M | Buy |
31,834
+457
| +1% | +$59.9K | 0.01% | 679 |
|
|
2020
Q4 | $3.28M | Buy |
31,377
+2,855
| +10% | +$298K | 0.01% | 680 |
|
|
2020
Q3 | $2.02M | Buy |
28,522
+12,695
| +80% | +$898K | 0.01% | 704 |
|
|
2020
Q2 | $1.02M | Buy |
+15,827
| New | +$1.02M | ﹤0.01% | 776 |
|